Family Legacy Inc’s Novo Nordisk NVO Stock Holding History

Family Legacy Inc’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$212K	Sell	4,417 -1,416	-24%	-$60.8K	0.06%	123
2026 Q1	$214K	Sell	5,833 -9,381	-62%	-$444K	0.06%	120
2025 Q4	$774K	Sell	15,214 -955	-6%	-$48.8K	0.23%	90
2025 Q3	$897K	Sell	16,169 -236	-1%	-$13.8K	0.27%	86
2025 Q2	$1.13M	Sell	16,405 -2,564	-14%	-$174K	0.37%	81
2025 Q1	$1.32M	Buy	18,969 +412	+2%	+$34K	0.45%	74
2024 Q4	$1.59M	Buy	18,557 +884	+5%	+$95.6K	0.54%	63
2024 Q3	$2.1M	Buy	17,673 +792	+5%	+$106K	0.7%	56
2024 Q2	$2.41M	Buy	16,881 +173	+1%	+$22.9K	0.86%	45
2024 Q1	$2.15M	Buy	16,708 +1,185	+8%	+$141K	0.77%	52
2023 Q4	$1.61M	Buy	+15,523	New	+$1.54M	0.61%	63

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Family Legacy Inc's NVO Position: Q2 2026 in Review

Family Legacy Inc reduced its Novo Nordisk (NVO) stake by 24% in Q2 2026, selling an estimated $60.8K and leaving 4,417 shares worth $212K. The position accounts for 0.06% of the portfolio, ranked #123.

Family Legacy Inc first reported a position in NVO in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.41M in Q2 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Family Legacy Inc held 4,417 shares of Novo Nordisk worth $212K as of Q2 2026.
Family Legacy Inc sold 1,416 Novo Nordisk shares in Q2 2026, an estimated $60.8K.
Novo Nordisk made up 0.06% of Family Legacy Inc's portfolio in Q2 2026, its #123 holding.
Family Legacy Inc first reported a position in Novo Nordisk in Q4 2023 and has held it in 11 quarters since.
Family Legacy Inc's Novo Nordisk position peaked at $2.41M in Q2 2024.
1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Family Legacy Inc's 13F filing for Q2 2026, filed 6 Aug 2026.